Table 1. Prevalence of Anti-Toxoplasma Antibodies by Trimester of First Screening.
| I trimester (group 1) |
II trimester (group 2) |
III trimester (group 3) |
Total | |||||
|---|---|---|---|---|---|---|---|---|
| Anti-Toxoplasma antibodies | No. | % (95% CI) | No. | % (95% CI) | No. | % (95% CI) | No. | % (95% CI) |
| IgG neg/IgM neg | 2975 | 75.3 (73.95-76.65) |
386 | 89.6 (86.72-92.48) |
273 | 86.9 (83.17-90.63) |
3634 | 77.4 (76.20-78.60) |
| IgG pos/IgM neg | 893 | 22.6 (21.29-23.90) |
44 | 10.2 (7.34-13.06) |
37 | 11.8 (8.23-15.37) |
974 | 20.7 (19.54-21.86) |
| IgG neg/IgM pos | 12 | 0.3 (0.13-0.47) |
0 | 0 (0.00-0.00) |
2 | 0.6 (0.00-1.45) |
14 | 0.3 (0.14-0.46) |
| IgG pos/IgM pos | 69 | 1.7 (1.30-2.10) |
1 | 0.2 (0.00-0.62) |
2 | 0.6 (0.00-1.45) |
72 | 1.5 (1.15-1.85) |
| Total | 3949 | 431 | 314 | 4694 | ||||
CI: Confidence Interval